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Abstract 
A potential impact of the centralisation of cancer services in the UK is difficulty in gaining access 
for members of the population living far from them. This could lead to delayed presentation of 
cancer with more advanced disease and clinical deterioration at diagnosis. A patient may be 
recorded in the cancer registry as having cancer of unknown primary (CUP) if the clinical state at 
presentation precludes investigation. Other patients may be so recorded if investigation 
identifies sites of metastatic tumour but the primary is not found. We hypothesised that the 
first group would include more patients who experienced difficulties in gaining access to health 
services through residing in deprived areas or through poorer geographical access to healthcare 
facilities. To test this, we compared the diagnosis of CUP with a comparator tumour, carcinoma 
of the rectum where diagnosis is facilitated by an alarm symptom and where variations in access 
are lower. Records from the Northern and Yorkshire Cancer Registry from 1994-2002 with ICD 
10 C77-C80 (CUP, including categories where investigations may have been incomplete or no 
primary cancer was found) and C20 (malignant neoplasm of rectum) were combined with travel 
time to services (primary care, secondary and tertiary services) and the Index of Multiple 
Deprivation (IMD). Logistic regression modelled predictors of CUP compared to C20 and, within 
CUP, the odds of a histological basis of diagnosis.  
 
The registry classified 7,428 patients as C80, 8,849 as C77-79, and 10,804 as C20. Compared to 
C20, the number of cases of C80 showed a statistically significant increasing trend with 
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increasing travel time to primary care.  Risk also increased strongly with age, and deprivation. 
Results for C77-C79 were similar to those for C80, except that the travel time to primary care 
showed no effect. Considering all CUP alone, histological diagnosis significantly declined with 
travel time to the nearest hospital. There was no association with sex and the likelihood of 
histological diagnosis, but a marked decline with age, a downward trend with deprivation, and 
an increase when the nearest hospital was a cancer centre. These findings facilitate the 
understanding of factors associated with the group of patients that includes those with the least 
effective access to cancer services. 
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4 
 
Introduction 
Policy for the management of cancer in the UK has been driven by the observation that at the 
end of the previous century, survival rates from cancer were worse in the UK than in 
comparable European countries [1]. The reasons continue to be debated but, following the NHS 
Cancer Plan [2] policies sought to improve the quality of care by increasing specialist 
recruitment and enhancing services in selected centres. Some specialist diagnostic and 
therapeutic services for cancer have been concentrated in selected large hospitals, known as 
Designated Cancer Centres. Typical district general hospitals, known as Designated Cancer Units, 
focus on the management of common cancers where high volumes can be sustained.  
A possible disadvantage of centralising services in this manner is that populations living further 
from specialist centres may have difficulties, including gaining transport to provide access to 
them for treatment, and such difficulties may consequently be associated with poorer disease 
prognosis [3,4]. Rural GPs have complained of the problems of gaining access to treatment for 
patients living in remoter areas far from cancer treatment centres [5] and a report from the 
Commission for Rural Communities has illustrated some adverse experiences of cancer sufferers 
and their carers living in rural England, with some patients facing round trips of 100 miles and 
the topography and quality of local roads further lengthening journey times [6]. There is 
accumulating evidence that longer travel times have negative effects on access to treatment 
and the outcome of care for patients with diagnosed cancer [7]. 
Campbell et al. [4] examined the relationship between survival and distance to cancer centres 
amongst 64,000 patients diagnosed with common cancers in Scotland between 1991 and 1995. 
They found that increasing distance from a cancer centre was associated with less chance of 
diagnosis before death for stomach, breast, and colorectal cancers and poorer survival after 
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diagnosis for prostate and lung cancers. A study of 5,147 cases of colorectal cancer in southern 
England [8] also found post-operative survival declined with increasing distance from a 
treatment centre.  
Our previous study of cancers of the breast, bowel, lung, prostate and ovary, which used 
records from the former Northern and Yorkshire Cancer Registry and Information Service 
(NYCRIS), added to the evidence. We found that survival from cancers of the prostate was 
adversely associated with travel time to the patient’s GP, as was the likelihood of presenting at 
late stage for breast or colorectal cancer [9]. Access to the centralised services of radiotherapy 
and thoracic surgery was shown to be reduced with increasing travel time, as was some 
chemotherapy [10] and the type of surgery used to treat breast cancer was influenced by access 
to radiotherapy [11]. These analyses adjusted for deprivation of the area of residence but more 
detailed analyses for lung cancer showed that the issues of access were minimal for the least 
deprived localities and greatest for the most deprived [12]. Similar observations were made for 
colonic but not rectal cancer; the symptom patterns of these tumours suggest that difficulty in 
suspecting the diagnosis was key [13]. There was also a tendency for those living furthest from a 
hospital to be recorded as having been diagnosed on the date of death [14].  
Cancer service development since 2000 initially concentrated on hospital services but more 
recently the focus has shifted to the timing of diagnosis [15]. This requires improvement in the 
interface between primary care, where GPs have to decide if it is appropriate to consider the 
diagnosis in a patient, and secondary care, where the facilities for investigation are located. For 
patients with common epithelial cancers, those from deprived areas have been shown to be 
more likely to have their first hospital admission as an emergency event [16]. Current 
understanding of the role of primary care in the process is discussed in the Lancet Oncology 
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Commission on the subject [17]. Practitioners in this discipline have a role throughout the 
cancer patient’s journey but it is especially important leading up to the diagnosis.  
There is concern about patients being admitted to hospital with previously undiagnosed cancer. 
The National Institute for Health and Care Excellence has issued a guideline for management of 
patients with malignancy of unknown primary [18], a decade after the Cancer Plan [2].  That 
document addresses the fact that this group of patients comprises two distinct entities; those 
patients whose primary site has not been identified because of presentation with very advanced 
disease and those in whom a primary cannot be identified. The first entity suggests that timely 
access to the diagnostic services of the Health Service has not been attained and in this study 
we investigate that process. We therefore decided to approach this entity in the same way and 
for the same time period over which we had looked at data concerning common cancer sites as 
an addition to the previous work. Taken as a whole, our body of work provides a detailed 
picture of the state of services at an important time point. 
We hypothesised that cancers of unknown primary would include more patients who faced 
difficulties in gaining access to health services through residing in deprived areas or through 
having to travel further to cancer facilities. To test this we compared the diagnosis of Cancer of 
Unknown Primary (CUP) with a comparator tumour, carcinoma of the rectum, where 
associations with access are not strong [13]. Indeed, few patients with rectal cancer require 
multiple consultations before a diagnosis is reached [19], most likely because it has a signature 
symptom of rectal bleeding. Undiagnosed rectal cancer is therefore unlikely to contribute 
greatly to the total of CUP patients.  The data we have analysed are from the time the Cancer 
Plan was being introduced and our results therefore form a historically relevant baseline against 
which the effects of that plan can be measured. 
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Materials and Methods 
Setting 
The study drew patients from the area covered by the former Northern and Yorkshire Cancer 
Registry & Information Service NYCRIS, which extended from the Scottish border to the Humber 
Estuary. The population covered was around 6.7 million. Approximately 17,500 new malignant 
cancer patients were assessed annually within this region during the period of study, and five 
year survival figures were lower than the national average for the majority of sites [20]. As well 
as widely distributed primary care services operated by general practitioners (GPs), the region 
contains 32 main acute hospitals (secondary care units) providing diagnostic and basic 
therapeutic services. Cancer Centres (specialist tertiary care units) are located in Hull, Leeds, 
Middlesbrough and Newcastle. The study area is predominantly rural and, in the counties of 
Northumberland and Cumbria, contains some of the most remote parts of Great Britain. The 
populations of some districts in those counties live an average distance of over 35km from their 
nearest main acute hospital, compared to a national average distance of under 9km [2]. The 
area also includes the urban conurbations of Leeds and Tyneside and other industrial cities, with 
significant pockets of inner-city deprivation. Among the hospitals that are not cancer centres we 
have not separately analysed data concerning those that had an in-house oncology service. 
These include several in West Yorkshire and Carlisle Infirmary, which has a radiotherapy facility.   
 
Subjects 
Records were supplied by NYCRIS for cancers registered from 1994 to 2002.  This period was 
chosen so that the findings were comparable with our previous work looking at different stages 
of the treatment/diagnosis pathway, described earlier [9-14].  NYCRIS supplied anonymous 
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records of patients registered with the following ICD 10 classifications: C77 (Secondary and 
unspecified malignant neoplasm of lymph nodes), C78 (Secondary malignant neoplasm of 
respiratory and digestive organs), C79 (Secondary malignant neoplasm of other sites), and C80 
(Malignant neoplasm without specification of site). C80 has the highest proportion of death 
certificate only and zero survival registrations and is likely to contain the patients whose 
presentation was with a clinical state that precluded further investigation. Data from ICD C20 
Carcinoma of rectum were supplied and used as a comparator site.  
The study was approved by the South Yorkshire Research Ethics Committee of the National 
Research Ethics Service. 
 
Accessibility and deprivation measures 
The travel time from the patients’ home postcode to their GP and the nearest cancer centre and 
hospital was calculated using the ArcGIS v9.3 Geographical Information System (GIS) package 
(ESRI Inc). In order to do this, a digital representation of the road network was constructed using 
the Ordnance Survey Meridian dataset [21] and network routing algorithms were used in the 
GIS to identify the most direct route along the road network from each patient’s home to their 
GP, the nearest cancer centre and nearest hospital. The total travel time in minutes for that 
route was then computed based on route length and the mix of road types. All calculations 
assumed car travel.  
As a measure of neighbourhood material deprivation, an Index of Multiple Deprivation (IMD) 
score [22] was calculated for each individual based on the Census Lower Super Output Area 
zone that their postcode fell within. We computed scores for the index minus the access to 
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services domain contribution to avoid duplication with our own access measures. To preserve 
anonymity, postcodes were removed from the records before they left the Registry for 
statistical analysis. 
 
Analysis 
Logistic regression was used to model predictors of CUP compared to carcinoma of the rectum. 
Models for C77-79 and C80 separately were adjusted for sex, age group, material deprivation 
quartile, and travel time to GP quartile.  For CUP patients only, we also modelled the travel time 
to the nearest hospital and whether the nearest hospital was a cancer centre.  Both of these 
models were adjusted for sex, age group and deprivation quartile. Tests for trend were carried 
out by fitting the values of the quartile number as a continuous variable. All analyses were 
carried out in Stata (version 14). 
 
Results 
In the dataset studied, 7,428 patients were classified as C80, 8,849 as C77-79, and 10,804 as 
C20.  Characteristics of patients in the analyses are summarised in Table 1. C20 patients were 
disproportionately male (62.2%).  CUP patients tended to be older, especially those classified as 
C80.  The table shows that fewer of the participants had travel time to their GP available than 
had the other travel time measurements as the postcode of the GP that these patients attended 
was not recorded in the cancer registry records. 
 
Table 2 gives the results from the logistic regression model, with the odds ratios for C80 
compared to C20 for sex, age group, deprivation quartile and travel time to GP quartile.  Travel 
time to GP showed a shallow gradient; odds ratios (ORs) (1.00, 1.09, 1.14) for quartiles 2-4 
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respectively, compared to the closest quartile 1, with p(trend)=0.007.  Compared to C20, there 
was a significant protective effect against being classified as C80 in males, but this is partly an 
artefact of the high number of males in the C20 group which reflects the known sex ratio for 
rectal cancer.  Risk of classification as C80 compared to C20 increased strongly with age, with 
the test for trend being highly significant (<0.001).  Risk of diagnosis of C80 compared to C20 
also increased with deprivation, p(trend)<0.001.   
 
Table 3 shows the corresponding results for C77-C79.  These were similar to those for C80, 
except that the travel time to GP showed no association, p(trend)=0.241. 
 
Table 4 shows the results of a logistic regression considering all CUP patients alone, and 
modelling the chance of a histological basis of diagnosis.  There was no association with sex and 
the likelihood of histological diagnosis, but an extremely strong association with age, with an OR 
as low as 0.063 for the 80+ group and p(trend)<0.001.  Histological diagnosis declined with 
deprivation, p(trend) <0.001 and less markedly with travel time to the nearest hospital; ORs 
(0.96, 0.88, 0.87) for quartiles 2-4, p(trend)=0.001.  There was a small but significant increased 
chance of a histological diagnosis if the nearest hospital was a cancer centre, OR=1.096 (95% CI 
1.012-1.087). 
 
The fitting of interaction terms suggested that deprivation did not moderate the association 
with travel time in any of the models.  
 
Discussion 
Main findings of the study 
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Compared to rectal cancer, risk of CUP diagnosis increased with age, deprivation and, for C80, 
travel time to GP.  For CUP patients, the chance of a histological basis of diagnosis decreased 
with age, deprivation and travel time to hospital and whether or not the nearest hospital was a 
cancer centre.   
 
What is already known on this topic? 
An American study found that a higher proportion of CUP was diagnosed in the elderly, females, 
black people and residents of less affluent or less educated counties [23].  A recent study of 
Scottish Cancer Registry data from 1961–2010 found that during 2001–2010, age-standardised 
rates of CUP were higher in the most compared with the least deprived quintile of the 
population [24].  They also found that CUP was unusual in people younger than 40 years and 
that rates increased quite steeply with age, although with some variation by sex and decade of 
incidence. 
 
What this study adds 
To our knowledge, no other studies have looked at travel time to locations of healthcare 
provision and CUP, or investigated the factors associated with the likelihood of a histological 
diagnosis in CUP patients.  This is the last in a series of studies based on cancer registry data 
from NYCRIS covering the period at the turn of the 20th century when the leadership of the NHS 
was recognising the shortfall in cancer survival that characterised the UK in comparison with 
other Western European economies. Whilst the Cancer Plan [2] was a major step in the process 
of improving hospital-based services concerned with cancer treatment, the question of what 
happens before the patient is seen in a hospital was not a focus until later that decade [15]. 
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Even now, GPs are aware of their paramount role as gatekeepers of the NHS whilst acting 
appropriately to allow timely diagnosis of cancer [17].  
Paramount in the development of understanding the importance of the timing of diagnosis was 
the recognition that much of the international difference in survival was accounted for by 
deaths in the first year.  Møller et al showed that differences in survival of patients with bowel 
cancer within England between socioeconomic groups were also apparent in the short term, 
that is poorer people are more likely to experience early death and the difference in survival 
between socioeconomic groups is much less for those who survive the first year [25]. Early 
death is likely to be a consequence of very advanced disease at the time of diagnosis. Our 
previous work has shown that there are differences in access to treatment for bowel cancer 
associated with socioeconomic status but these are relatively small for rectal cancer [13].  This 
led us to use rectal cancer as the reference group in this study. 
In studying patients registered as having cancer without a primary site being specified we 
acknowledge that when the diagnosis is not confirmed histologically, some patients will not 
actually have cancer; the diagnosis is inferred from clinical and radiological findings. Indeed, we 
have two groups of patients which overlap in the ICD classifications. Some patients are not fully 
investigated, commonly because of severe comorbidity or because the underlying cancer is 
causing them to be very ill. This category is expected to form the bulk of the C80 classification. It 
represents patients in whom the cancer diagnostic services have, for whatever reason, been 
least successful. 
The second group consists of patients in whom investigations fail to reveal the primary; this is a 
recognised entity requiring specialist treatment. These patients will mostly be included in 
categories C77-C79 along with some patients in C80. For these patients palliative systemic 
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therapy is available but this should not be given without a histological diagnosis. Attainment of 
this step is therefore a measure of active management of the patient. In addition to the strong 
effects of age and deprivation, we have shown that whether or not the nearest hospital is a 
cancer centre influences it. This is likely to reflect the perceived utility of the precise diagnosis 
which in turn reflects what treatment is thought potentially appropriate. Whether or not an 
oncological opinion is brought is readily available will be relevant here.  In the period since these 
patients were registered we have seen the development of multidisciplinary teams, in fulfilment 
of the Cancer Plan [2] and of acute oncology services. These should reduce the difference 
between the types of institutions. 
It may be argued that new investigative techniques may decrease the number of patients 
designated CUP.  The NICE Guidance proposes a conservative approach to investigation in the 
light of limited evidence [18]. It does not advocate the use of magnetic resonance imaging 
except in the assessment of lymphadenopathy that might be due to breast cancer. Similarly, 
recommendations for imaging that includes positron emission tomography advises its use only 
in cervical lymphadenopathy when an aerodigestive primary is possible. It is therefore not likely 
that their introduction to routine practice will have had an impact on the situation we have 
found.  
The delivery of up-to-date cancer services has been a major endeavour within the National 
Health Service within the past 20 years after it became apparent that there were weaknesses 
compared with comparable European countries. Lyratzopoulos et al have explored the issue of 
diagnostic delay when patients have come to the attention of a GP [26]. They argue that 
diagnosis may be swifter if facilitated by decision support interventions, better interactions 
between generalists and specialists, and easier access to diagnostics. In this respect, the 
14 
 
characteristics we have found to be associated with a higher likelihood of being diagnosed with 
CUP are very similar to the characteristics associated with early death after a diagnosis of lung 
cancer [27]. 
Much has been done to improve the process for patients who come to specialist attention and 
current efforts are aimed at improving the timeliness of the initiation of diagnostic processes. To 
this must be added the need to understand the barriers that prevent potential cancer patients 
from seeking an explanation for their symptoms. We have studied a group of patients which 
includes those who are least well served by the process. This sets a baseline against which 
improvements in access to diagnosis can be measured. In particular, we found a higher 
likelihood of histological confirmation of CUP, with the implication of greater diagnostic 
endeavour and expertise, when the nearest hospital was a cancer centre; yet this disparity may 
become less pronounced with enhanced performance throughout the NHS. Further, our findings 
suggest that the increased travel times typically experienced by patients attending cancer units 
may be detrimental to some. In addition, whilst the association between CUP and 
socioeconomic status has been noted before, with CUP generally being over-represented by 
those from more deprived backgrounds [28], we believe this is one of the first studies to assess 
socioeconomic status in connection with access to services. 
 
Limitations of this study 
We were not able to separate those patients presenting too unwell for investigation to be 
appropriate from those who were able to be investigated and were not, and those who were 
thoroughly investigated but no primary tumour was found. We would anticipate that C80 would 
mostly contain the first group and that most of the second and third groups would be in C77-79. 
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For comparison with previous results, this study was based on data for patients diagnosed 
between 1994 and 2002.  This has the advantage, however, of establishing a baseline to 
measure the effects of changes in policy and practice.  In fact, the focus on diagnosis in UK 
policy and the formulation of a policy for Metastasis of Unknown Origin (MUO) occurred much 
more recently with guidance being published in 2010 [18] and so our observations are likely to 
have retained their relevance until the start of the current decade. Studies of current patients 
will assess what effect they are having. Our own recent work in lung cancer confirms that major 
geographical variations in access to services persisted at least until 2010 in spite of the efforts to 
develop services [29]. 
Our study is cross-sectional in nature, so we cannot determine if the associations we have seen 
are causal.  We had no information on patient ethnicity or individual conditions or 
characteristics beyond age and sex, and we relied on an area-based measure of deprivation, the 
IMD.  This was a surrogate for individual measures of disadvantage, which were unavailable.  
Our measure of deprivation may thus be subject to the ecological fallacy [30], where patients 
living in a deprived area were not themselves deprived, but our large sample size reduces the 
expected effects of this factor.  We had data on travel time to GP for a smaller number of 
patients (5697, 64% of the total); those for whom this information was available may not be 
representative of all patients. 
Much of the cancer registry information is obtained by individuals who are not clinicians and 
who may not have access to every detail of the patient’s clinical record.  This will result in some 
patients inappropriately being recorded as CUP. One Australian study [31] audited 574 cancer 
registry CUP diagnoses (C80.9) and found that 30.0% of cases were reclassified to a known 
primary site, mostly cutaneous, and 1.6% were found to be non-malignant; some of our patients 
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will not have had cancer and some will have had diagnoses unknown to us. If the distribution of 
such error is random, the effect will have been to dilute the associations between age, travel 
time, deprivation and institution type that we have seen.  
 
Conclusions 
We have found that, in the time period we have studied and compared to rectal cancer, risk of 
CUP diagnosis increases for C80 with travel time to GP.  For all registry categories of CUP 
patients, the chance of a histological basis of diagnosis decreases with travel time to hospital 
and increases when that hospital is a cancer centre.  As the NHS continues to press for timelier 
ascertainment of cases of cancer in order that patients can best benefit from treatment it 
should be expected that the adverse trends that we have shown for deprivation and travel time 
to care will be reduced. It is also important to recognise that the gateway to care will be through 
the hospital first encountered, so all NHS institutions providing a diagnostic service should be 
able to do this effectively whether or not they are designated cancer centres. 
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Table 1: Characteristics of study participants 
 
 C77-C79  C80  C20 
 n %  n %  n % 
Sex         
  Female 4,459 50.4  4,057 54.6  4,085 37.8 
  Male 4,390 49.6  3,371 45.4  6,719 62.2 
         
Age at diagnosis (y)         
  <50 395 4.5  269 3.6  591 5.5 
  50-59 919 10.4  590 7.9  1,432 13.3 
  60-69 1,989 22.5  1,310 17.6  2,890 26.8 
  70-79 3,215 36.3  2,647 35.6  3,626 33.6 
  80+ 2,331 26.3  2,612 35.2  2,265 21.0 
          
Deprivation (IMD Score)         
  Quartile 1 (least deprived) 2,140 24.2  1,556 21.0  3,080 28.5 
  Quartile 2 2,227 25.2  1,882 25.3  2,655 24.6 
  Quartile 3 2,260 25.5  1,906 25.7  2,607 24.1 
  Quartile 4 (most deprived) 2,222 25.1  2,084 28.1  2,462 22.8 
         
Estimated travel time to GP         
  Quartile 1 (0-<2.9 mins) 1,433 25.2  1,081 25.4  2,333 24.8 
  Quartile 2 (2.9-<5.3 mins) 1,472 25.8  1,018 23.9  2,353 25.0 
  Quartile 3 (2.3-<9.1 mins) 1,368 24.0  1,101 25.9  2,382 25.3 
  Quartile 4 (9.1-231.7 mins) 1,424 25.0  1,056 24.8  2,357 25.0 
         
Travel time to nearest cancer centre        
  Quartile 1 (0.1-<6.1 mins) 2,209 25.0  1,970 26.5  2,649 24.5 
  Quartile 2 (6.1-<27.4 mins) 2,260 25.5  1,909 25.7  2,640 24.4 
  Quartile 3 (27.4-<38.8 mins) 2,156 24.4  1,795 24.2  2,737 25.3 
  Quartile 4 (38.8-195.0 mins) 2,224 25.1  1,754 23.6  2,778 25.7 
         
Travel time to nearest hospital         
  Quartile 1 (0.1-<7.6 mins) 2,272 25.7  1,889 25.4  2,416 22.4 
  Quartile 2 (7.6-<11.6 mins) 2,194 24.8  1,908 25.7  2,754 25.5 
  Quartile 3 (11.6-<17.1 mins) 2,214 25.0  1,854 25.0  2,771 25.7 
  Quartile 4 (17.1-117.5 mins) 2,169 24.5  1,777 23.9  2,863 26.5 
         
Histological basis of diagnosis         
  No 4,542 51.3  5,639 75.9    
  Yes 4,307 48.7  1,789 24.1    
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Table 2: Odds ratio for cancer of unknown primary (compared to C20, rectal carcinoma), 
adjusted for sex, age group, deprivation quartile and travel time to GP quartile for ICD code 
C80 (n=13,681) 
 
 Odds ratio 95% CI P-value P-trend 
Sex     
 Female 1.000    
 Male 0.561 0.520-0.605 <0.001  
     
Age at diagnosis (y)     
 <50 1.000    
 50-59 1.030 0.819-1.294 0.802  
 60-69 1.219 0.990-1.503 0.063  
 70-79 1.841 1.504-2.253 <0.001  
 80+ 2.455 2.000-3.014 <0.001 <0.001 
     
Deprivation (IMD Score)     
 Quartile 1 (least deprived) 1.000    
 Quartile 2 1.532 1.371-1.712 <0.001  
 Quartile 3 1.739 1.557-1.941 <0.001  
 Quartile 4 (most deprived) 2.067 1.853-2.305 <0.001 <0.001 
     
Travel time to GP     
 Quartile 1 (0-<2.9 mins) 1.000    
 Quartile 2 (2.9-<5.3 mins) 1.003 0.902-1.115 0.959  
 Quartile 3 (2.3-<9.1 mins) 1.091 0.983-1.212 0.102  
 Quartile 4 (9.1-231.7 mins) 1.135 1.020-1.262 0.020 0.007 
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Table 3: Odds ratio for cancer of unknown primary (compared to rectal carcinoma, C20), 
adjusted for sex, age group, deprivation quartile, travel time to GP quartile for ICD codes C77-
C79 (n=15,122) 
 
 Odds ratio 95% CI P-value P-trend 
Sex     
 Female 1.000    
 Male 0.612 0.572-0.655 0.000  
     
Age at diagnosis (y)     
 <50 1.000    
 50-59 1.029 0.852-1.241 0.769  
 60-69 1.165 0.981-1.385 0.082  
 70-79 1.458 1.232-1.725 <0.001  
 80+ 1.594 1.341-1.895 <0.001 <0.001 
     
Deprivation (IMD score)     
 Quartile 1 (least deprived) 1.000    
 Quartile 2 1.342 1.219-1.477 <0.001  
 Quartile 3 1.415 1.285-1.557 <0.001  
 Quartile 4 (most deprived) 1.598 1.453-1.758 <0.001 <0.001 
     
Travel time to GP     
 Quartile 1 (0-<2.9 mins) 1.000    
 Quartile 2 (2.9-<5.3 mins) 1.061 0.966-1.166 0.214  
 Quartile 3 (2.3-<9.1 mins) 0.992 0.902-1.091 0.862  
 Quartile 4 (9.1-231.7 mins) 1.087 0.988-1.196 0.088 0.241 
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Table 4: Odds ratio for histological basis of diagnosis adjusted for sex, age group, deprivation 
quartile, travel time to nearest hospital quartile and whether the nearest hospital was a 
cancer centre for ICD codes C77-C80 (n=16,277) 
 
 Odds ratio 95% CI P-value P-trend 
Sex     
 Female 1.000    
 Male 0.978 0.913-1.048 0.543  
     
Age at diagnosis (y)     
 <50 1.000    
 50-59 0.521 0.422-0.644 <0.001  
 60-69 0.321 0.264-0.390 <0.001  
 70-79 0.152 0.126-0.184 <0.001  
 80+ 0.063 0.052-0.076 <0.001 <0.001 
     
Deprivation (IMD score)     
 Quartile 1 (least deprived) 1.000    
 Quartile 2 0.752 0.681-0.830 <0.001  
 Quartile 3 0.667 0.604-0.736 <0.001  
 Quartile 4 (most deprived) 0.618 0.559-0.684 <0.001 <0.001 
     
Travel time to nearest hospital     
 Quartile 1 (0.1-<7.6 mins) 1.000    
 Quartile 2 (7.6-<11.6 mins) 0.956 0.868-1.052 0.358  
 Quartile 3 (11.6-<17.1 mins) 0.881 0.800-0.971 0.011  
 Quartile 4 (17.1-117.5 mins) 0.876 0.792-0.968 0.010 0.003 
     
Nearest hospital was a cancer centre     
 No 1.000    
 Yes 1.096 1.012-1.187 0.025  
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